The management of anemia in dialysis patients also needs to consider the appearance of symptoms and whether erythropoiesis-stimulating agents (EPO) are used for treatment (KDOQI Clinical Practice Guidelines for Anemia of CKD). The gene discussed is EPO; the disease is chronic kidney disease.